https://doi.org/10.4081/hmr.v1i9.313

Tissue factor pathway inhibitor and cancer

Vol. 1 No. 9: 3rd International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, October 14-16, 2005
Published: June 3, 2009
Abstract Views: 154
PDF: 594
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Y Gruel
support@pagepress.org
J Rollin
S Regina
S Iochmann
F Hube
P Reverdiau
The coagulation protease cascade and the fibrinolytic system are leading to the synthesis of two serine-proteases that are essential for normal hemostasis but these enzymes also play important regulatory roles in angiogenesis, cancer cell migration and tumor growth. Tissue factor (TF) is the physiological trigger of coagulation cascade and is mainly regulated by TFPI-1 (tissue factor pathway inhibitor), a kunitz-domain serine protease inhibitor. But, another protein analogous to TFPI-1 and named TFPI-2 is also present in large amounts in extracellular matrices (ECM), and has been identified as playing an important role in cancer invasion.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Gruel, Y., Rollin, J., Regina, S., Iochmann, S., Hube, F., & Reverdiau, P. (2009). Tissue factor pathway inhibitor and cancer. Hematology Meeting Reports (formerly Haematologica Reports), 1(9). https://doi.org/10.4081/hmr.v1i9.313
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).